Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Prevnar
Biotech
Vaxcyte surges on 'stunning' 31-valent PCV win against Pfizer
Vaxcyte unveiled what analysts called “stunning” phase 1/2 data for its 31-valent pneumococcal vaccine candidate.
Angus Liu
Sep 3, 2024 10:32am
Merck compares pneumococcal vaccine to 1983 warhorse
Apr 29, 2024 9:00am
Merck strides onto Pfizer’s turf with pivotal vaccine data
Nov 28, 2023 8:20am
Merck's next-gen pneumococcal vaccine receives breakthrough tag
Apr 14, 2022 9:35am
Affinivax nabs huge $226M funding round
Jan 8, 2021 8:35am
